Published in Physician Law Weekly, February 1st, 2006
This extension is subject to review by the NYSE on an ongoing basis. Should the company be unable to meet this deadline, it may request up to an additional 2 months to file its 2004 Form 10-K, which request will be subject to formal re-evaluation by the NYSE.
On December 19, 2005, the company announced that it anticipated filing its 2004 Form 10-K on or about January 31, 2006.
Bradley Pharmaceuticals acquires...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly